Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / equity
-
Shares outstanding
-
106M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
72.3M
-
Shares change
-
+2.93M
-
Total reported value, excl. options
-
$197M
-
Value change
-
+$5.45M
-
Number of buys
-
50
-
Number of sells
-
-57
-
Price
-
$2.73
Significant Holders of MAXCYTE, INC. - equity (MXCT) as of Q1 2025
129 filings reported holding MXCT - MAXCYTE, INC. - equity as of Q1 2025.
MAXCYTE, INC. - equity (MXCT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.3M shares
of 106M outstanding shares and own 68.36% of the company stock.
Largest 10 shareholders include CADIAN CAPITAL MANAGEMENT, LP (10M shares), BlackRock, Inc. (8.17M shares), MORGAN STANLEY (7M shares), VANGUARD GROUP INC (5.57M shares), Vitruvian Partners LLP (5.04M shares), MIRABELLA FINANCIAL SERVICES LLP (3.7M shares), Mudita Advisors LLP (3.33M shares), FMR LLC (2.94M shares), GEODE CAPITAL MANAGEMENT, LLC (2.58M shares), and Chevy Chase Trust Holdings, LLC (2.23M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.